Pharmeasy IPO (API Holdings IPO) GMP & Best Review 2021
According to RedSeer Report, API Holdings Limited is India’s biggest online healthcare platform (depending on GMV of items and solutions provided for the year ended March 31, 2021). Pharmeasy IPO (API Holdings IPO) will hit the market in February 2021.
About API Holdings
We run an integrated, end-to-end business with the goal of meeting users’ healthcare requirements at all phases of the process: supplying electronic tools and details on disease and wellbeing, offering teleconsultation, giving diagnostics and radiology tests, and distributing treatment protocols, such as products and devices.
The skills that set us apart are their custom-built proprietary system, unified data portals, supply chain skills, and deep awareness of the dynamic interplay between the numerous sub-segments of India’s healthcare sector.
Their platforms are available throughout India’s major cities and rural areas.
Footprints
Their technology tools and capabilities help clients address problems while also allowing them to take advantage of a linked network.
At the same time, they help them to establish a larger presence, allowing their platform to reach a larger number of stakeholders across the country.
their operations are spread around the country, with last-mile delivery capabilities in over 18,587 pin codes (as of June 2021) via the PharmEasy marketplace, enabling them to provide service to the ordinary man at an affordable price.
Their platforms have grown to serve people from all walks of life and across India’s urban, semi-urban, and rural areas.
History
Dialhealth.com was founded by several of their Founders (Siddharth, Hardik, and Harsh) in 2012. It was an online order platform that provided tele-consultation, diagnostic lab pick-ups, and medical supply delivery services.
Despite the fact that these Founders had several offers, they only observed significant demand for product delivery, and as a result, offerings other than product delivery were subsequently pared back.
As Ascent grew, its procurement and supply chain capabilities improved, prompting their Founders to apply what they’d learned to create the technology that supports the PharmEasy marketplace.
PharmEasy is a healthcare smart app that allows users to get pharmaceutical medications on-demand and have them delivered to their homes.
Pharmeasy IPO
API Holdings Limited, headquartered in Mumbai has submitted Draft Red Herring Prospectus(DRHP) to Securities and Exchange Board of India(SEBI) for initial public offering (IPO) of INR 6,250 crores on 08 November 2021.
The offer includes fresh issue of INR 6200 crores value equity shares and there is no offer for sale (OFS) by the promoters mentioned in the DRHP. They are looking for a pre-IPO placement of 1,250 crores in this issue.
They are now waiting for approval from Securities and Exchange Board of India(SEBI) to float the initial public offering (IPO) in the market.
Originally published at https://profitmust.com on November 11, 2021.
